Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
This article was originally published in The Tan Sheet
Executive Summary
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
You may also be interested in...
Omega-3 Petition Seeks Unqualified Blood Pressure, CHD Claims
The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.
Omega-3 Petition Seeks Unqualified Blood Pressure, CHD Claims
The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.
Qualified Health Claim Study Should Test Letter Grades, SSA Claims – CHPA
FDA should study consumer perceptions of qualified health claims by testing statements that contain both "report card" grades and text ratings, as well as claims that do not bear a letter grade, the Consumer Healthcare Products Association says in recent comments to the agency